Allarity Therapeutics, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $0.00.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $565.00K, a 48.29% increase year-over-year.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $60.00K.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $1.38M, a 578.33% increase from fiscal 2022.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $203.00K, a 2800.00% increase from fiscal 2021.
- Allarity Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $7.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $1.38M 10-K · filed 2024-03-08 | |
| 2023-03-31 | $565.00K 10-Q · filed 2024-08-05 | |
| 2022-12-31 | $203.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $60.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $26.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $381.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $7.00K 10-K · filed 2023-03-13 | |
| 2020-09-30 | $1.58M 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |